Male-pattern hair loss, or androgenetic alopecia, is an androgenic condition par excellence. However, a randomized-controlled trial assigning men to receive 50, 125, 300 or 600 mg weekly of testosterone enanthate for 20 weeks found no difference in sebum production between groups (22). This is supported by the observations that androgen-insensitive patients have no detectable sebum production (60), and that sebum production decreases in response to estrogen and antiandrogen administration (61). Androgens play a pivotal role in sebum production as it has an absolute androgen dependency. After your first Dianabol cycle, you can only stack anabol with Testosterone Enanthate. Methandienone Dianabol comes in pill form, making it an oral steroid. This is one of the best-known steroids primarily because it is considered safer than many of the other options on the market. Anabolic steroids target the androgen receptor, the natural biological receptor for testosterone and its metabolite dihydrotestosterone. Some examples of anabolic steroids are nandrolone, oxandrolone, oxymetholone, stanozolol, and trenbolone acetate. Testosterone suppression is also a big concern with anabolic steroids; anabol is no exception. Anabol is relatively low on the androgenic stakes compared to other steroids. Even though they can still be prescribed by a medical doctor in the U.S., the use of anabolic steroids for injury recovery purposes has been a taboo subject, even amongst the majority of sports medicine doctors and endocrinologists. Although the term "anabolic–androgenic steroid" is technically valid in describing two types of actions of these agents, Handelsman considers the term to be unnecessary and redundant. It is widely used therapeutically, in various esterified forms, as replacement therapy in male hypogonadism. Clinicians may use this review as a guide for understanding how AAS use can impact health and to assist in patient education and, in some cases, the management of side effects. This review provides an up-to-date and comprehensive overview on how these hormones work and what side effects they might elicit. Healthcare providers sometimes prescribe anabolic steroids for other conditions. Healthcare providers provide corticosteroids much more often than anabolic steroids. Anabolic steroids are manufactured drugs that closely resemble the hormone testosterone or other androgens. Approximately 3 to 4 million people in the United States use anabolic steroids for nonmedical purposes. Conversion of testosterone to DHT can accelerate the rate of premature baldness for males genetically predisposed, but testosterone itself can produce baldness in females. Most of these side-effects are dose-dependent, the most common being elevated blood pressure, especially in those with pre-existing hypertension. Studies indicate that the anabolic properties of AAS are relatively similar despite the differences in pharmacokinetic principles such as first-pass metabolism. In addition, because estered testosterone is dissolved in oil, intravenous injection has the potential to cause a dangerous embolism (clot) in the bloodstream. Designer steroids are AAS that have not been approved and marketed for medical use but have been distributed through the black market. According to one study, AAS users also distrust their physicians and in the sample 56% had not disclosed their AAS use to their physicians. Some data about the development of clitoromegaly are available from research in female-to-male transsexual patients. Lower dosages up to 6.25 mg weekly did not, suggesting a threshold for developing hirsutism in response to testosterone at a dosage somewhere between 6.25 and 12.5 mg weekly. Mild hirsutism occurs in around 1 out of 5 women given 150 mg testosterone enanthate every 4 weeks and is reversible after cessation of use (223). These effects include dysphonia or deepening of the voice, hirsutism and clitoromegaly. Almost all of them had Simon grade 1 gynecomastia, with one subject progressing from Simon grade 2 at the end of the AAS cycle to grade 3 three months after the cycle, presumably due to the hypogonadal state that followed after cessation of use. A variety of conditions that affect the levels or actions of these sex hormones can therefore cause gynecomastia. The condition remains prevalent throughout adulthood, with one study reporting gynecomastia in 40.5% of healthy young men aged 18–26 years (199) and another reporting detectable palpable breast tissue in 36% of healthy adult men aged 16–58 years (200). While these drugs are commonly already acquired by AAS users from the black market, they might be prescribed to patients suffering from erectile dysfunction which is either organic or psychogenic in nature. Side effects include headache, flushing, dyspepsia, nasal congestion, dizziness, transient abnormal vision and cyanopsia (specific to sildenafil), and back pain and myalgia (specific to tadalafil) (196). Some AAS users self-medicate with phosphodiesterase type 5 (PDE5) inhibitors such as sildenafil to counteract erectile dysfunction (65). In support of the model is the rare condition congenital 5α-reductase type 2 deficiency, in which the 5α-reductase type 2 enzyme is defective, production of DHT is impaired, and DHT levels are low while testosterone levels are normal. Body weight in men may increase by 2 to 5 kg as a result of short-term (muscle hypertrophy and the formation of new muscle fibers have been observed. The hydration of lean mass remains unaffected by AAS use, although small increments of blood volume cannot be ruled out. This disassociation is less marked in humans, where all AAS have significant androgenic effects. Through a number of mechanisms AAS stimulate the formation of muscle cells and hence cause an increase in the size of skeletal muscles, leading to increased strength. Other effects include, but are not limited to, accelerated bone maturation, increased frequency and duration of erections, and premature sexual development. For example, AAS may prematurely stop the lengthening of bones (premature epiphyseal fusion through increased levels of estrogen metabolites), resulting in stunted growth.
